Children's Oncology Group

Arcadia, California 91006-3776

0 studies enrolling now · 48 studies all time

What they study most

AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, AIDS-related Immunoblastic Large Cell Lymphoma, AIDS-related Lymphoblastic Lymphoma, AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, AIDS-related Small Noncleaved Cell Lymphoma, Accelerated Phase Chronic Myelogenous Leukemia, Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma

Studies at this site

• Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology Group — Running, not enrolling
• Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia — Completed
• Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases — Completed
• Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma — Completed
• Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma — Completed
• Systemic Chemotherapy and Subtenon Carboplatin, and Local Ophthalmic Therapy in Children With Intraocular Retinoblastoma — Completed
• Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma — Completed
• Vincristine, Carboplatin, and Etoposide or Observation Only in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Retinoblastoma — Completed
• Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma — Completed
• Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant — Completed
• Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant — Completed
• Study of Blood Samples From Patients With Osteosarcoma — Completed
• Gene Expression Profiles to Categorize Wilms Tumors — Completed
• Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic Leukemia — Completed
• Response or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With Methotrexate — Completed
• Bortezomib in Treating Children With Advanced Solid Tumors — Completed
• Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood — Completed
• Ixabepilone in Treating Young Patients With Refractory Solid Tumors — Completed
• Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma — Completed
• Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia — Completed
• Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia — Completed
• Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma — Completed
• Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia — Stopped early
• Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma — Completed
• Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma — Completed
• Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal Tumor — Completed
• 506U78 in Treating Patients With Refractory Hematologic Cancer — Completed
• Diagnostic Study of Tumor Characteristics in Patients With Ewing's Sarcoma — Completed
• Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma — Completed
• Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer — Completed
• Irinotecan in Treating Children With Refractory Solid Tumors — Completed
• Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment — Completed
• Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplant in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia — Completed
• Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment — Completed
• Dasatinib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate — Completed
• Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma — Completed
• Gefitinib in Treating Children With Refractory Solid Tumors — Completed
• Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia — Stopped early
• Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors — Completed
• Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma — Completed
• Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia — Completed
• Radiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Lymphoma — Stopped early
• Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma — Completed
• FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia — Completed
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome — Completed
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia — Completed
• Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma — Completed
• Motexafin Gadolinium Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma — Completed